An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)
Status:
Withdrawn
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of this clinical trial
is to investigate the safety, tolerability, pharmacokinetics and signs of bioactivity of
increasing repeated doses of NNC 151-0000-0000 in subjects with Systemic Lupus Erythematosus
(SLE).